This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Summit At ChinaBio Partnering Forum
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026
Menu

Ting He
Founder and CEO at Imunopharm Technology Co., Ltd.
Speaker

Profile

Dr. He Ting, CEO of Imunopharm Technology Co., Ltd., has been engaged in the research and development of anti-tumor cell and gene therapies (CGT) and is a leading figure in China's CGT industry. He led his team to develop a one-stop technology platform from 0 to 1, obtaining 8 NMPA and 2 FDA CAR-T IND approvals.

Agenda Sessions

  • From Lab to Bedside: Navigating the Pathway of Unmet Medical Needs in Late Stage Solid Tumor Treatment through Cost-Effective CAR-T Therapy

    , 14:00
    View Session

At this event

Prev
Next
Nicoletta Loggia
Chief Technical Officer
Orchard Therapeutics

See Ting at Cell & Gene Therapy Summit At ChinaBio Partnering Forum